Obesity and cardiovascular disease: an ESC clinical consensus statement

KC Koskinas, EM Van Craenenbroeck… - European Heart …, 2024 - academic.oup.com
The global prevalence of obesity has more than doubled over the past four decades,
currently affecting more than a billion individuals. Beyond its recognition as a high-risk …

Efficacy of semaglutide by sex in obesity-related heart failure with preserved ejection fraction: STEP-HFpEF trials

S Verma, J Butler, BA Borlaug, M Davies… - Journal of the American …, 2024 - jacc.org
Background More women than men have heart failure with preserved ejection fraction
(HFpEF). Objectives The purpose of this study was to assess baseline characteristics and …

[HTML][HTML] Weight reduction interventions for the management of atrial fibrillation in overweight and obese people

H Valli, A Tindale, H Butt, CJ Beattie… - The Cochrane …, 2024 - ncbi.nlm.nih.gov
Weight reduction interventions for the management of atrial fibrillation in overweight and obese
people - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

Investigative agents for atrial fibrillation: agonists and stimulants, progress and expectations

R Casado-Arroyo, M Bernardi, P Sabouret… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Atrial fibrillation (AF) is the most common type of cardiac arrhythmia. Its
prevalence has increased due to worldwide populations that are aging in combination with …

[HTML][HTML] The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists in the Management of Obesity-Related Heart Failure with Preserved Ejection Fraction …

P Karakasis, N Fragakis, D Patoulias, P Theofilis… - Biomedicines, 2024 - mdpi.com
Obesity is a significant predisposing factor for heart failure with preserved ejection fraction
(HFpEF). Although a substantial proportion of individuals with HFpEF also have obesity …

Effect of Obesity on the Use of Antiarrhythmics in Adults With Atrial Fibrillation: A Narrative Review

F Shaikh, R Wynne, RL Castelino… - Clinical …, 2024 - Wiley Online Library
Background Atrial fibrillation (AF) and obesity coexist in approximately 37.6 million and 650
million people globally, respectively. The anatomical and physiological changes in …

[HTML][HTML] Left Atrial Appendage Thrombus as a Marker of Disease Severity in 500 Patients with Atrial Fibrillation on Oral Anticoagulation: A 13-Year Follow-Up Study

Ł Turek, M Sadowski, J Kurzawski… - Journal of Clinical …, 2024 - mdpi.com
Background/Objective: Whether left atrial appendage thrombus (LAAT) in patients with atrial
fibrillation (AF) on chronic anticoagulation significantly increases cardiovascular risk is …

[HTML][HTML] Atrial Fibrillation Prevalence Rates and Its Association with Cardiovascular–Kidney–Metabolic Factors: SIMETAP-AF Study

A Ruiz-García, A Serrano-Cumplido… - Medicina, 2024 - mdpi.com
Background and Objectives: Atrial fibrillation (AF) is the most frequent arrhythmia and the
main cause of hospital admissions for cardioembolic stroke. The SIMETAP research project …

The burden of atrial fibrillation/flutter in the Middle East and North Africa region and its associated risk factors from 1990 to 2019

M Yaghoubi, PH Roumiani, F Nozari, S Simiyari… - BMC Cardiovascular …, 2024 - Springer
Background Atrial fibrillation and flutter (AFF) are the most common cardiac arrhythmias
globally, contributing to substantial morbidity and mortality. The Middle East and North Africa …

[HTML][HTML] Trends and Disparities in Arrhythmia-Related Deaths among Older Adults in the United States, 1999-2020

MRS Cheema, AJ Nashwan - Journal of Medicine, Surgery, and Public …, 2024 - Elsevier
This study examines mortality trends and disparities in arrhythmia-related deaths among
older adults in the United States from 1999 to 2020. Utilizing mortality data from the CDC …